Cargando…

Revisiting the risks of MRI with Gadolinium based contrast agents—review of literature and guidelines

ABSTRACT: Gadolinium based contrast agents (GBCA) have been linked to the occurrence of nephrogenic systemic fibrosis (NSF) in renal impaired patients. The exact interaction between the various different available formulations and occurrence of NSF is not completely understood, but has been postulat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Khawaja, Aurang Z., Cassidy, Deirdre B., Al Shakarchi, Julien, McGrogan, Damian G., Inston, Nicholas G., Jones, Robert G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2015
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4569598/ https://www.ncbi.nlm.nih.gov/pubmed/26253982 http://dx.doi.org/10.1007/s13244-015-0420-2

Ejemplares similares

Current tools for prediction of arteriovenous fistula outcomes
por: McGrogan, Damian G., et al.
Publicado: (2015)

End-stage vascular access failure: can we define and can we classify?
por: Al Shakarchi, Julien, et al.
Publicado: (2015)

Preoperative assessment for percutaneous and open surgical arteriovenous fistula creation in patients for haemodialysis
por: Khawaja, Aurang Z, et al.
Publicado: (2020)

Preoperative assessment for percutaneous and open surgical arteriovenous fistula creation in patients for haemodialysis
por: Khawaja, Aurang Z, et al.
Publicado: (2019)

Maintaining Patency of Vascular Access for Haemodialysis
por: Inston, Nicholas, et al.
Publicado: (2017)

Biocompatible Polyhydroxyethylaspartamide-based Micelles with Gadolinium for MRI Contrast Agents
por: Jeong, Sang Young, et al.
Publicado: (2010)

Timing of cannulation of arteriovenous grafts: are we too cautious?
por: Al Shakarchi, Julien, et al.
Publicado: (2015)

Gadolinium contrast agents: Over exposure?
por: Biederman, Robert W, et al.
Publicado: (2016)

Single- and Multi-Arm Gadolinium MRI Contrast Agents for Targeted Imaging of Glioblastoma
por: Patil, Rameshwar, et al.
Publicado: (2020)

Peptide-Based Soft Hydrogels Modified with Gadolinium Complexes as MRI Contrast Agents
por: Gallo, Enrico, et al.
Publicado: (2020)

Fatal anaphylactic reaction to intravenous gadobutrol, a gadolinium-based MRI contrast agent
por: Franckenberg, Sabine, et al.
Publicado: (2017)

Synthesis of a gadolinium based-macrocyclic MRI contrast agent for effective cancer diagnosis
por: Jeong, Yohan, et al.
Publicado: (2018)

Subsequent MRI of pediatric patients after an adverse reaction to Gadolinium-based contrast agents
por: Hojreh, Azadeh, et al.
Publicado: (2020)

Gadolinium-doped fluorescent carbon quantum dots as MRI contrast agents and fluorescent probes
por: Molaei, Mohammad Jafar
Publicado: (2022)

Gadolinium-Based Contrast Agents in Pregnant Women: A Literature Review of MRI Safety
por: Alghamdi, Sami A
Publicado: (2023)

Gadolinium-DTPA: A New Contrast Agent
por: Niendorf, H. P.
Publicado: (1988)

Comparing the signal enhancement of a gadolinium based and an iron-oxide based contrast agent in low-field MRI
por: van Zandwijk, Jordy K., et al.
Publicado: (2021)

Aneurysms and pseudoaneurysms in dialysis access
por: Mudoni, Anna, et al.
Publicado: (2015)

Evaluating the potential of chelation therapy to prevent and treat gadolinium deposition from MRI contrast agents
por: Rees, Julian A., et al.
Publicado: (2018)

The Effect of Magnetic Field Gradient and Gadolinium-Based MRI Contrast Agent Dotarem on Mouse Macrophages
por: Chanana, Priyanka, et al.
Publicado: (2022)

Linear Gadolinium-Based Contrast Agents Are Associated With Brain Gadolinium Retention in Healthy Rats
por: Robert, Philippe, et al.
Publicado: (2016)

Gadolinium Complexes as Contrast Agent for Cellular NMR Spectroscopy
por: Sakol, Nat, et al.
Publicado: (2020)

Gadolinium retention within multiple rat organs after intra-articular administration of gadolinium-based contrast agents
por: Ringler, Michael D., et al.
Publicado: (2021)

Gadolinium contrast agents- challenges and opportunities of a multidisciplinary approach: Literature review
por: Iyad, Nebal, et al.
Publicado: (2023)

Is the Transport of a Gadolinium-Based Contrast Agent Decreased in a Degenerated or Aged Disc? A Post Contrast MRI Study
por: Tibiletti, Marta, et al.
Publicado: (2013)

Fibromyalgia associated with repeated gadolinium contrast-enhanced MRI examinations
por: Lattanzio, Silvia Maria, et al.
Publicado: (2020)

MRI spot sign: Gadolinium contrast extravasation in an expanding intracerebral hematoma on MRI
por: Allam, Talha, et al.
Publicado: (2019)

Gadolinium: pharmacokinetics and toxicity in humans and laboratory animals following contrast agent administration
por: Davies, Julie, et al.
Publicado: (2022)

Immediate reaction to gadolinium based contrast agent with fatal outcome()()()
por: Behzadi, Ashkan Heshmatzadeh, et al.
Publicado: (2018)

Gadolinium-Based Contrast Agents Hypersensitivity: A Case Series
por: Nucera, Eleonora, et al.
Publicado: (2021)

Gadolinium-based contrast agents in neurofibromatosis type 1 (Review)
por: Năstase, Florentina, et al.
Publicado: (2021)

Recent Advances in Gadolinium Based Contrast Agents for Bioimaging Applications
por: Fatima, Atiya, et al.
Publicado: (2021)

The presence of the gadolinium-based contrast agent depositions in the brain and symptoms of gadolinium neurotoxicity - A systematic review
por: Olchowy, Cyprian, et al.
Publicado: (2017)

Gadolinium deposition in the brain of dogs after multiple intravenous administrations of linear gadolinium based contrast agents
por: Richter, Henning, et al.
Publicado: (2020)

Gadolinium‐based contrast agent exposures and physical and cognitive disability in multiple sclerosis
por: Nakamura, Kunio, et al.
Publicado: (2022)

Gadolinium(III) Complexes with N-Alkyl-N-methylglucamine Surfactants Incorporated into Liposomes as Potential MRI Contrast Agents
por: Silva, Simone Rodrigues, et al.
Publicado: (2015)

The potential toxic impact of different gadolinium-based contrast agents combined with 7-T MRI on isolated human lymphocytes
por: Friebe, Björn, et al.
Publicado: (2018)

Glucosamine Conjugated Gadolinium (III) Oxide Nanoparticles as a Novel Targeted Contrast Agent for Cancer Diagnosis in MRI
por: T., Mortezazadeh, et al.
Publicado: (2020)

MRI Contrast Agents in Glycobiology
por: Geraldes, Carlos F. G. C., et al.
Publicado: (2022)

Geometrical confinement of gadolinium-based contrast agents in nanoporous particles enhances T(1) contrast
por: Ananta, Jeyarama S., et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_2q1q69h3b2tvfcin54u8itt57r